# Phillips Medisize acquires Chippenham facility to expand inhalation center of excellence

Phillips Medisize, a Molex company, announced an investment to acquire the complete footprint of its Chippenham site (58,963 square meters) to strengthen its Global Inhalation Center of Excellence, providing additional capacity for drug-device combination product development and manufacturing.

- Type: Acquisition
- Announced: 2026-11-05
- Where: Chippenham, England, United Kingdom
- Status: completed
- Capacity: 58,963 square meters
- Products: inhalation drug delivery devices, drug-device combination products
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Phillips-Medisize Corporation](https://endata.com/companies/20563.md) (acquirer)
- [Molex](https://endata.com/companies/20564.md) (investor)

## Sources

- [businesswire.com](https://www.businesswire.com/news/home/20261105864022/en/Phillips-Medisize-Acquires-Chippenham-Facility-to-Expand-Global-Inhalation-Center-of-Excellence), 2026-11-05: "Phillips Medisize, a Molex company and a leader in the design, development, engineering and manufacturing of pharmaceutical drug delivery, in vitro diagnostic and medtech devices, today announced an investment to acquire the complete footprint of its Chippenham site."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.